{
    "2023-03-31": {
        "Tax Effect Of Unusual Items": -24100.0,
        "Tax Rate For Calcs": 0.241,
        "Normalized EBITDA": 48000000.0,
        "Total Unusual Items": -100000.0,
        "Total Unusual Items Excluding Goodwill": -100000.0,
        "Net Income From Continuing Operation Net Minority Interest": 24300000.0,
        "Reconciled Depreciation": 12200000.0,
        "Reconciled Cost Of Revenue": 180300000.0,
        "EBIT": 35700000.0,
        "Net Interest Income": -3700000.0,
        "Interest Expense": 3700000.0,
        "Interest Income": NaN,
        "Normalized Income": 24375900.0,
        "Net Income From Continuing And Discontinued Operation": 24300000.0,
        "Total Expenses": 269900000.0,
        "Total Operating Income As Reported": 35900000.0,
        "Diluted Average Shares": 18682268.0,
        "Basic Average Shares": 18449430.0,
        "Diluted EPS": 1.3,
        "Basic EPS": 1.32,
        "Diluted NI Availto Com Stockholders": 24300000.0,
        "Net Income Common Stockholders": 24300000.0,
        "Net Income": 24300000.0,
        "Net Income Including Noncontrolling Interests": 24300000.0,
        "Net Income Continuous Operations": 24300000.0,
        "Tax Provision": 7700000.0,
        "Pretax Income": 32000000.0,
        "Other Income Expense": -200000.0,
        "Other Non Operating Income Expenses": -100000.0,
        "Special Income Charges": NaN,
        "Gain On Sale Of Ppe": NaN,
        "Gain On Sale Of Security": -100000.0,
        "Net Non Operating Interest Income Expense": -3700000.0,
        "Interest Expense Non Operating": 3700000.0,
        "Interest Income Non Operating": NaN,
        "Operating Income": 35900000.0,
        "Operating Expense": 89600000.0,
        "Research And Development": 7900000.0,
        "Selling General And Administration": 81700000.0,
        "Gross Profit": 125500000.0,
        "Cost Of Revenue": 180300000.0,
        "Total Revenue": 305800000.0,
        "Operating Revenue": 305800000.0
    },
    "2022-12-31": {
        "Tax Effect Of Unusual Items": -28800.0,
        "Tax Rate For Calcs": 0.036,
        "Normalized EBITDA": 28900000.0,
        "Total Unusual Items": -800000.0,
        "Total Unusual Items Excluding Goodwill": -800000.0,
        "Net Income From Continuing Operation Net Minority Interest": 23800000.0,
        "Reconciled Depreciation": 12600000.0,
        "Reconciled Cost Of Revenue": 175800000.0,
        "EBIT": 28100000.0,
        "Net Interest Income": -3400000.0,
        "Interest Expense": 3400000.0,
        "Interest Income": NaN,
        "Normalized Income": 24571200.0,
        "Net Income From Continuing And Discontinued Operation": 23800000.0,
        "Total Expenses": 262600000.0,
        "Total Operating Income As Reported": 28400000.0,
        "Diluted Average Shares": 18685605.0,
        "Basic Average Shares": 18490547.0,
        "Diluted EPS": 1.27,
        "Basic EPS": 1.29,
        "Diluted NI Availto Com Stockholders": 23800000.0,
        "Net Income Common Stockholders": 23800000.0,
        "Net Income": 23800000.0,
        "Net Income Including Noncontrolling Interests": 23800000.0,
        "Net Income Continuous Operations": 23800000.0,
        "Tax Provision": 900000.0,
        "Pretax Income": 24700000.0,
        "Other Income Expense": -300000.0,
        "Other Non Operating Income Expenses": 500000.0,
        "Special Income Charges": 0.0,
        "Gain On Sale Of Ppe": 0.0,
        "Gain On Sale Of Security": -800000.0,
        "Net Non Operating Interest Income Expense": -3400000.0,
        "Interest Expense Non Operating": 3400000.0,
        "Interest Income Non Operating": NaN,
        "Operating Income": 28400000.0,
        "Operating Expense": 86800000.0,
        "Research And Development": 7600000.0,
        "Selling General And Administration": 79200000.0,
        "Gross Profit": 115200000.0,
        "Cost Of Revenue": 175800000.0,
        "Total Revenue": 291000000.0,
        "Operating Revenue": 291000000.0
    },
    "2022-09-30": {
        "Tax Effect Of Unusual Items": 0.0,
        "Tax Rate For Calcs": 0.212,
        "Normalized EBITDA": 33300000.0,
        "Total Unusual Items": 0.0,
        "Total Unusual Items Excluding Goodwill": 0.0,
        "Net Income From Continuing Operation Net Minority Interest": 15600000.0,
        "Reconciled Depreciation": 11300000.0,
        "Reconciled Cost Of Revenue": 162200000.0,
        "EBIT": 22000000.0,
        "Net Interest Income": -2200000.0,
        "Interest Expense": 2200000.0,
        "Interest Income": NaN,
        "Normalized Income": 15600000.0,
        "Net Income From Continuing And Discontinued Operation": 15600000.0,
        "Total Expenses": 241500000.0,
        "Total Operating Income As Reported": 21400000.0,
        "Diluted Average Shares": 18691916.0,
        "Basic Average Shares": 18515851.0,
        "Diluted EPS": 0.83,
        "Basic EPS": 0.84,
        "Diluted NI Availto Com Stockholders": 15600000.0,
        "Net Income Common Stockholders": 15600000.0,
        "Net Income": 15600000.0,
        "Net Income Including Noncontrolling Interests": 15600000.0,
        "Net Income Continuous Operations": 15600000.0,
        "Tax Provision": 4200000.0,
        "Pretax Income": 19800000.0,
        "Other Income Expense": 600000.0,
        "Other Non Operating Income Expenses": 600000.0,
        "Special Income Charges": 0.0,
        "Gain On Sale Of Ppe": 0.0,
        "Gain On Sale Of Security": NaN,
        "Net Non Operating Interest Income Expense": -2200000.0,
        "Interest Expense Non Operating": 2200000.0,
        "Interest Income Non Operating": NaN,
        "Operating Income": 21400000.0,
        "Operating Expense": 79300000.0,
        "Research And Development": 7900000.0,
        "Selling General And Administration": 71400000.0,
        "Gross Profit": 100700000.0,
        "Cost Of Revenue": 162200000.0,
        "Total Revenue": 262900000.0,
        "Operating Revenue": 262900000.0
    },
    "2022-06-30": {
        "Tax Effect Of Unusual Items": 491400.0,
        "Tax Rate For Calcs": 0.182,
        "Normalized EBITDA": 30900000.0,
        "Total Unusual Items": 2700000.0,
        "Total Unusual Items Excluding Goodwill": 2700000.0,
        "Net Income From Continuing Operation Net Minority Interest": 16600000.0,
        "Reconciled Depreciation": 12100000.0,
        "Reconciled Cost Of Revenue": 174100000.0,
        "EBIT": 21500000.0,
        "Net Interest Income": -1200000.0,
        "Interest Expense": 1200000.0,
        "Interest Income": 0.0,
        "Normalized Income": 14391400.0,
        "Net Income From Continuing And Discontinued Operation": 16600000.0,
        "Total Expenses": 261100000.0,
        "Total Operating Income As Reported": 22800000.0,
        "Diluted Average Shares": 18683798.0,
        "Basic Average Shares": 18507073.0,
        "Diluted EPS": 0.89,
        "Basic EPS": 0.9,
        "Diluted NI Availto Com Stockholders": 16600000.0,
        "Net Income Common Stockholders": 16600000.0,
        "Net Income": 16600000.0,
        "Net Income Including Noncontrolling Interests": 16600000.0,
        "Net Income Continuous Operations": 16600000.0,
        "Tax Provision": 3700000.0,
        "Pretax Income": 20300000.0,
        "Other Income Expense": 2400000.0,
        "Other Non Operating Income Expenses": -300000.0,
        "Special Income Charges": 3700000.0,
        "Gain On Sale Of Ppe": 3700000.0,
        "Gain On Sale Of Security": -1000000.0,
        "Net Non Operating Interest Income Expense": -1200000.0,
        "Interest Expense Non Operating": 1200000.0,
        "Interest Income Non Operating": 0.0,
        "Operating Income": 19100000.0,
        "Operating Expense": 87000000.0,
        "Research And Development": 7900000.0,
        "Selling General And Administration": 79100000.0,
        "Gross Profit": 106100000.0,
        "Cost Of Revenue": 174100000.0,
        "Total Revenue": 280200000.0,
        "Operating Revenue": 280200000.0
    }
}